Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

1.

Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression.

Salín-Pascual RJ, Rosas M, Jimenez-Genchi A, Rivera-Meza BL, Delgado-Parra V.

J Clin Psychiatry. 1996 Sep;57(9):387-9.

PMID:
9746444
[PubMed - indexed for MEDLINE]
2.

Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.

Feighner JP, Overø K.

J Clin Psychiatry. 1999 Dec;60(12):824-30.

PMID:
10665628
[PubMed - indexed for MEDLINE]
3.

Relationship between mood improvement and sleep changes with acute nicotine administration in non-smoking major depressed patients.

Salin-Pascual RJ.

Rev Invest Clin. 2002 Jan-Feb;54(1):36-40.

PMID:
11995405
[PubMed - indexed for MEDLINE]
4.

Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial.

Feiger AD, Rickels K, Rynn MA, Zimbroff DL, Robinson DS.

J Clin Psychiatry. 2006 Sep;67(9):1354-61.

PMID:
17017821
[PubMed - indexed for MEDLINE]
5.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
[PubMed - indexed for MEDLINE]
6.

Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder.

Feiger AD, Heiser JF, Shrivastava RK, Weiss KJ, Smith WT, Sitsen JM, Gibertini M.

J Clin Psychiatry. 2003 Mar;64(3):243-9.

PMID:
12716264
[PubMed - indexed for MEDLINE]
7.

Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.

Mehtonen OP, Søgaard J, Roponen P, Behnke K.

J Clin Psychiatry. 2000 Feb;61(2):95-100.

PMID:
10732656
[PubMed - indexed for MEDLINE]
8.

Mirtazapine compared with paroxetine in major depression.

Benkert O, Szegedi A, Kohnen R.

J Clin Psychiatry. 2000 Sep;61(9):656-63.

PMID:
11030486
[PubMed - indexed for MEDLINE]
9.

A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving.

Docherty JP, Sack DA, Roffman M, Finch M, Komorowski JR.

J Psychiatr Pract. 2005 Sep;11(5):302-14.

PMID:
16184071
[PubMed - indexed for MEDLINE]
10.

Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study.

Silver AA, Shytle RD, Philipp MK, Wilkinson BJ, McConville B, Sanberg PR.

J Clin Psychiatry. 2001 Sep;62(9):707-14.

PMID:
11681767
[PubMed - indexed for MEDLINE]
11.

Effects of transderman nicotine on mood and sleep in nonsmoking major depressed patients.

Salín-Pascual RJ, de la Fuente JR, Galicia-Polo L, Drucker-Colín R.

Psychopharmacology (Berl). 1995 Oct;121(4):476-9.

PMID:
8619011
[PubMed - indexed for MEDLINE]
12.

Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.

Alpert JE, Franznick DA, Hollander SB, Fava M.

J Clin Psychiatry. 2004 Aug;65(8):1069-75.

PMID:
15323591
[PubMed - indexed for MEDLINE]
13.

Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.

Elliott AJ, Russo J, Bergam K, Claypoole K, Uldall KK, Roy-Byrne PP.

J Clin Psychiatry. 1999 Apr;60(4):226-31.

PMID:
10221282
[PubMed - indexed for MEDLINE]
14.

Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.

Sonawalla SB, Spillmann MK, Kolsky AR, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M.

J Clin Psychiatry. 1999 Sep;60(9):580-3.

PMID:
10520975
[PubMed - indexed for MEDLINE]
15.

Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial.

McClernon FJ, Hiott FB, Westman EC, Rose JE, Levin ED.

Psychopharmacology (Berl). 2006 Nov;189(1):125-33. Epub 2006 Sep 15.

PMID:
16977477
[PubMed - indexed for MEDLINE]
17.

Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg/day dose.

Beasley CM Jr, Nilsson ME, Koke SC, Gonzales JS.

J Clin Psychiatry. 2000 Oct;61(10):722-8.

PMID:
11078032
[PubMed - indexed for MEDLINE]
18.

The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?

Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM.

J Clin Psychiatry. 2004 Apr;65(4):521-30.

PMID:
15119915
[PubMed - indexed for MEDLINE]
19.

Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study.

Saiz-Ruiz J, Ibañez A, Díaz-Marsá M, Arias F, Carrasco JL, Huertas D, Martín-Carrasco M, Moreno I, Rico-Villademoros F.

CNS Drugs. 2002;16(9):635-43.

PMID:
12153334
[PubMed - indexed for MEDLINE]
20.

Relationship of mood disturbance to cigarette smoking status among 252 patients with a current mood disorder.

Patten CA, Gillin JC, Golshan S, Wolter TD, Rapaport M, Kelsoe J.

J Clin Psychiatry. 2001 May;62(5):319-24.

PMID:
11411811
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk